docetaxel anhydrous has been researched along with Constriction, Pathologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Inaki, N; Kinoshita, J; Moriyama, H; Nakamura, K; Okamoto, K; Saito, H; Shimada, M; Tsuji, T; Yamaguchi, T | 1 |
| Gillis, A; Leyssens, B; Lobelle, JP; Mombaerts, I; Paridaens, R; Wildiers, H | 1 |
| Esmaeli, B | 1 |
1 review(s) available for docetaxel anhydrous and Constriction, Pathologic
| Article | Year |
|---|---|
Management of excessive tearing as a side effect of docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Conjunctivitis; Constriction, Pathologic; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Taxoids | 2005 |
1 trial(s) available for docetaxel anhydrous and Constriction, Pathologic
| Article | Year |
|---|---|
A double-blind randomized phase II study on the efficacy of topical eye treatment in the prevention of docetaxel-induced dacryostenosis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Constriction, Pathologic; Docetaxel; Double-Blind Method; Female; Humans; Lacrimal Apparatus Diseases; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Ophthalmic Solutions; Taxoids; Treatment Outcome | 2010 |
1 other study(ies) available for docetaxel anhydrous and Constriction, Pathologic
| Article | Year |
|---|---|
Impact of preoperative docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy on degree of malignant esophageal stenosis.
Topics: Cisplatin; Constriction, Pathologic; Deglutition Disorders; Docetaxel; Esophageal Stenosis; Fluorouracil; Humans | 2023 |